U.S. Active Pharmaceutical Ingredients CDMO Market Will Grow Rapidly In Coming Years
U.S. Active Pharmaceutical Ingredients CDMO Market Summary The U.S. Active Pharmaceutical Ingredients CDMO Market was valued at USD 25.28 billion in 2024 and is projected to reach USD 33.86 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2030. This growth is largely attributed to the increasing need for advanced pharmaceutical manufacturing capabilities that support the development of new and innovative drugs and therapies. In particular, rising investments in biologics and high-potency APIs (HPAPIs) continue to play a significant role in driving market expansion. Furthermore, the escalating incidence of chronic diseases necessitates scalable and efficient API production solutions to meet rising therapeutic demands. Key growth drivers in this market include continuous advancements in process chemistry, as well as increasing automation in pharmaceutical manufacturing. These innovations enable higher yield, reduced waste, and impr...